Limited coverage drugs – deferiprone

Generic name



100 mg/mL, 1000 mg


oral solution, tablet

Special Authority criteria

Approval period

Treatment of transfusion-dependent iron overload due to thalassemia syndromes, where iron chelation therapy is required, according to established criteria*, and when prescribed by a hematologist.

Initial request: 1 year

Renewal request: 1 year

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)

* Click on the Special Authority Form below for full criteria: